ID Corner: A Case of Varicella Zoster Virus Reactivation Post COVID-19 Immunization
by Aaron Klysen, BSPS, 2022 PharmD Candidate, Kasey Arnhoelter, PharmD, BCPS
"Recent efforts to slow the COVID-19 pandemic have focused largely on immunization. With COVID-19 vaccines being readily available, approximately 55% of the United States population is now fully vaccinated, with many citizens having received one of the two available mRNA products. Both mRNA vaccines, produced by Pfizer and Moderna, have proven to be safe and effective in clinical trials.1,2 Since their introduction to the public, under Food and Drug Administration Emergency Use Authorization, the Vaccine Adverse Events Reporting System (VAERS) has continued to collect data on adverse events surrounding COVID-19 vaccination. Furthermore, anecdotal case reports have been published throughout the vaccination period on potential, but rare, adverse effects. Below, we present a case of herpes zoster status –post-COVID-19 vaccination with Pfizer’s BNT162b2 vaccine."
Keywords: COVID-19 Vaccines, Tacrolimus, Valacyclovir, Prednisone, COVID-19, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Kidney Transplantation, Diabetes Mellitus, Type 2, Cephalexin, Vaccines, Immunosuppression, Pain, Fatigue, Physical Examination, Hospitals, Herpes Zoster, Patient Reported Outcome Measures
Download PDF
2021 November/December Table of Contents
"Recent efforts to slow the COVID-19 pandemic have focused largely on immunization. With COVID-19 vaccines being readily available, approximately 55% of the United States population is now fully vaccinated, with many citizens having received one of the two available mRNA products. Both mRNA vaccines, produced by Pfizer and Moderna, have proven to be safe and effective in clinical trials.1,2 Since their introduction to the public, under Food and Drug Administration Emergency Use Authorization, the Vaccine Adverse Events Reporting System (VAERS) has continued to collect data on adverse events surrounding COVID-19 vaccination. Furthermore, anecdotal case reports have been published throughout the vaccination period on potential, but rare, adverse effects. Below, we present a case of herpes zoster status –post-COVID-19 vaccination with Pfizer’s BNT162b2 vaccine."
Keywords: COVID-19 Vaccines, Tacrolimus, Valacyclovir, Prednisone, COVID-19, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Kidney Transplantation, Diabetes Mellitus, Type 2, Cephalexin, Vaccines, Immunosuppression, Pain, Fatigue, Physical Examination, Hospitals, Herpes Zoster, Patient Reported Outcome Measures
Download PDF
2021 November/December Table of Contents